SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-05-000741
Filing Date
2005-02-25
Accepted
2005-02-25 14:30:53
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w06145e10vk.htm 10-K 803596
2 EXHIBIT 21 w06145exv21.htm EX-21 1263
3 EXHIBIT 23.1 w06145exv23w1.htm EX-23.1 2040
4 EXHIBIT 23.2 w06145exv23w2.htm EX-23.2 2498
5 EXHIBIT 31.1 w06145exv31w1.htm EX-31.1 7865
6 EXHIBIT 31.2 w06145exv31w2.htm EX-31.2 8371
7 EXHIBIT 32.1 w06145exv32w1.htm EX-32.1 3904
8 EXHIBIT 32.2 w06145exv32w2.htm EX-32.2 4097
  Complete submission text file 0000950133-05-000741.txt   835947
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26301 | Film No.: 05640575
SIC: 2834 Pharmaceutical Preparations